Putrescine reduces antibiotic-induced oxidative stress as a mechanism of modulation of antibiotic resistance in Burkholderia cenocepacia

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 4162-4171

  El Halfawy, Omar M ^a,b   Valvano, Miguel A ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Alexandria University Faculty of Pharmacy   (Egypt)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOACETIC ACID DERIVATIVE; CEFTAZIDIME; DICHLOROFLUORESCEIN; GENTAMICIN; HYDROGEN PEROXIDE; NORFLOXACIN; ORNITHINE DECARBOXYLASE; POLYMYXIN B; PUTRESCINE; REACTIVE OXYGEN METABOLITE; RIFAMPICIN; SUPEROXIDE; ANTIINFECTIVE AGENT; CARBOXYLYASE; LYSINE DECARBOXYLASE;

ANTIBIOTIC INDUCED OXIDATIVE STRESS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BIOSYNTHESIS; BURKHOLDERIA CENOCEPACIA; CONTROLLED STUDY; DELETION MUTANT; ENZYME SYNTHESIS; FLUOROMETRY; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MODULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; WILD TYPE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CENOCEPACIA; CARBOXY-LYASES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HYDROGEN PEROXIDE; MICROBIAL SENSITIVITY TESTS; ORNITHINE DECARBOXYLASE; OXIDATIVE STRESS; POLYMYXIN B; PUTRESCINE;

EID: 84903193890     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02649-14     Document Type: Article

References (45)

1. Ejim L, Farha MA, Falconer SB, Wildenhain J, Coombes BK, Tyers M, Brown ED, Wright GD. 2011. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7:348-350. http://dx.doi.org/10.1038/ nchembio.559.
2. Waters V. 2012. New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Curr. Pharm. Des. 18:696-725. http://dx.doi.org/10.2174/ 138161212799315939.
3. Loutet SA, Valvano MA. 2010. A decade of Burkholderia cenocepacia virulence determinant research. Infect. Immun. 78:4088-4100. http://dx.doi.org/10.1128/IAI.00212-10.
4. Corey M, Farewell V. 1996. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am. J. Epidemiol. 143:1007-1017. http://dx.doi.org/10. 1093/oxfordjournals.aje.a008664. (Pubitemid 26140328)
5. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. 2002. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg. Infect. Dis. 8:181-187. http://dx.doi.org/10.3201/eid0802.010163. (Pubitemid 34202443)
6. Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ. 2001. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 139:643-649. http://dx.doi.org/10.1067/mpd.2001.118430.
7. De Soyza A, Ellis CD, Khan CM, Corris PA, Demarco de Hormaeche R. 2004. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am. J. Respir. Crit. Care Med. 170:70-77. http://dx.doi.org/10.1164/ rccm.200304-592OC. (Pubitemid 38997754)
8. El-Halfawy OM, Valvano MA. 2012. Non-genetic mechanisms communicating antibiotic resistance: rethinking strategies for antimicrobial drug design. Expert Opin. Drug Discov. 7:923-933. http://dx.doi.org/10.1517/17460441.2012. 712512.
9. Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL. 2003. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 123:1495-1502. http://dx.doi.org/10.1378/chest.123.5.1495. (Pubitemid 36549768)
10. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. 2012. Polymicrobial interactions: impact on pathogenesis and human disease. Clin. Microbiol. Rev. 25:193-213. http://dx.doi.org/10.1128/CMR.00013-11.
11. Goytia M, Shafer WM. 2010. Polyamines can increase resistance of Neisseria gonorrhoeae to mediators of the innate human host defense. Infect. Immun. 78:3187-3195. http://dx.doi.org/10.1128/IAI.01301-09.
12. El-Halfawy OM, Valvano MA. 2013. Chemical communication of antibiotic resistance by a highly resistant subpopulation of bacterial cells. PLoS One 8:e68874. http://dx.doi.org/10.1371/journal.pone.0068874.
13. Tabor CW, Tabor H. 1984. Polyamines. Annu. Rev. Biochem. 53:749-790. http://dx.doi.org/10.1146/annurev.bi.53.070184.003533. (Pubitemid 14059150)
14. Wortham BW, Patel CN, Oliveira MA. 2007. Polyamines in bacteria: pleiotropic effects yet specific mechanisms. Adv. Exp. Med. Biol. 603:106-115. http://dx.doi.org/10.1007/978-0-387-72124-8-9.
15. Johnson L, Mulcahy H, Kanevets U, Shi Y, Lewenza S. 2012. Surface-localized spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic treatment and oxidative stress. J. Bacteriol. 194:813-826. http://dx.doi.org/10.1128/JB.05230-11.
16. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. http://dx.doi.org/10.1016/j.cell.2007.06.049. (Pubitemid 47332566)
17. Tkachenko AG, Akhova AV, Shumkov MS, Nesterova LY. 2012. Polyamines reduce oxidative stress in Escherichia coli cells exposed to bactericidal antibiotics. Res. Microbiol. 163:83-91. http://dx.doi.org/10.1016/j.resmic.2011. 10.009.
18. Kolodkin-Gal I, Sat B, Keshet A, Engelberg-Kulka H. 2008. The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics. PLoS Biol. 6:e319. http://dx.doi.org/10.1371/journal. pbio.0060319.
19. Choi H, Lee DG. 2012. Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria. Res. Microbiol. 163:479-486. http://dx.doi.org/10.1016/j.resmic.2012.06.001.
20. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K. 2013. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339:1213-1216. http://dx.doi.org/10.1126/science.1232688.
21. Liu Y, Imlay JA. 2013. Cell death from antibiotics without the involvement of reactive oxygen species. Science 339:1210-1213. http://dx.doi.org/10.1126/science.1232751.
22. Imlay JA. 2008. Cellular defenses against superoxide and hydrogen peroxide. Annu. Rev. Biochem. 77:755-776. http://dx.doi.org/10.1146/annurev. biochem.77.061606.161055.
23. Sambrook J, Fritsch EF, Maniatis T. 1990. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
24. Cohen SN, Chang AC, Hsu L. 1972. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. U. S. A. 69:2110-2114. http://dx.doi.org/10.1073/pnas.69.8. 2110.
25. Craig FF, Coote JG, Parton R, Freer JH, Gilmour NJ. 1989. A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J. Gen. Microbiol. 135:2885-2890. (Pubitemid 19286730)
26. Figurski DH, Helinski DR. 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. U. S. A. 76:1648-1652. http://dx.doi.org/10.1073/pnas.76. 4.1648. (Pubitemid 9175374)
27. Tkachenko AG, Fedotova MV. 2007. Dependence of protective functions of Escherichia coli polyamines on strength of stress caused by superoxide radicals. Biochemistry (Mosc.) 72:109-116. http://dx.doi.org/10.1134/S0006297907010130. (Pubitemid 46219194)
28. Ortega XP, Cardona ST, Brown AR, Loutet SA, Flannagan RS, Campopiano DJ, Govan JR, Valvano MA. 2007. A putative gene cluster for amino-arabinose biosynthesis is essential for Burkholderia cenocepacia viability. J. Bacteriol. 189:3639-3644. http://dx.doi.org/10.1128/JB.00153-07. (Pubitemid 46668829)
29. Iwase T, Tajima A, Sugimoto S, Okuda K, Hironaka I, Kamata Y, Takada K, Mizunoe Y. 2013. A simple assay for measuring catalase activity: a visual approach. Sci. Rep. 3:3081. http://dx.doi.org/10.1038/srep03081.
30. Rhee SG, Chang TS, Jeong W, Kang D. 2010. Methods for detection and measurement of hydrogen peroxide inside and outside of cells. Mol. Cells 29:539-549. http://dx.doi.org/10.1007/s10059-010-0082-3.
31. Chou HT, Kwon DH, Hegazy M, Lu CD. 2008. Transcriptome analysis of agmatine and putrescine catabolism in Pseudomonas aeruginosa PAO1. J. Bacteriol. 190:1966-1975. http://dx.doi.org/10.1128/JB.01804-07. (Pubitemid 351355319)
32. Renggli S, Keck W, Jenal U, Ritz D. 2013. The role of autofluorescence in flow-cytometric analysis of Escherichia coli treated with bactericidal antibiotics. J. Bacteriol. 195:4067-4073. http://dx.doi.org/10.1128/JB.00393-13.
33. Kooy NW, Royall JA, Ischiropoulos H. 1997. Oxidation of 2′,7′-dichlorofluorescein by peroxynitrite. Free Radic. Res. 27:245-254. http://dx.doi.org/10.3109/10715769709065763.
34. Aslund F, Zheng M, Beckwith J, Storz G. 1999. Regulation of the OxyR transcription factor by hydrogen peroxide and the cellular thiol-disulfide status. Proc. Natl. Acad. Sci. U. S. A. 96:6161-6165. http://dx.doi.org/10.1073/ pnas.96.11.6161. (Pubitemid 29256636)
35. Tkachenko AG, Nesterova LY. 2003. Polyamines as modulators of gene expression under oxidative stress in Escherichia coli. Biochemistry (Mosc.) 68:850-856. http://dx.doi.org/10.1023/A:1025790729797.
36. Reen FJ, Haynes JM, Mooij MJ, O'Gara F. 2013. A non-classical LysR-type transcriptional regulator PA2206 is required for an effective oxidative stress response in Pseudomonas aeruginosa. PLoS One 8:e54479. http://dx.doi.org/10. 1371/journal.pone.0054479.
37. Vander Wauven C, Stalon V. 1985. Occurrence of succinyl derivatives in the catabolism of arginine in Pseudomonas cepacia. J. Bacteriol. 164:882-886. (Pubitemid 16191867)
38. Stalon V, Mercenier A. 1984. L-Arginine utilization by Pseudomonas species. J. Gen. Microbiol. 130:69-76. (Pubitemid 14188283)
39. Grasemann H, Shehnaz D, Enomoto M, Leadley M, Belik J, Ratjen F. 2012. L-Ornithine derived polyamines in cystic fibrosis airways. PLoS One 7:e46618. http://dx.doi.org/10.1371/journal.pone.0046618.
40. Twomey KB, Alston M, An SQ, O'Connell OJ, McCarthy Y, Swarbreck D, Febrer M, Dow JM, Plant BJ, Ryan RP. 2013. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation. PLoS One 8: e82432. http://dx.doi.org/10.1371/journal.pone.0082432.
41. Laube BL, Sharpless G, Benson J, Carson KA, Mogayzel PJ, Jr. 2014. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa. J. Pediatr. 164:839-845. http://dx.doi.org/10.1016/j. jpeds.2013.11.031.
42. Yoder-Himes DR, Konstantinidis KT, Tiedje JM. 2010. Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One 5:e8724. http://dx.doi.org/10.1371/journal.pone. 0008724.
43. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:910-913. (Pubitemid 30082711)
44. Moore RA, Reckseidler-Zenteno S, Kim H, Nierman W, Yu Y, Tuanyok A, Warawa J, DeShazer D, Woods DE. 2004. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect. Immun. 72:4172-4187. http://dx.doi.org/10.1128/IAI.72.7.4172-4187.2004. (Pubitemid 38821932)
45. Bernier SP, Nguyen DT, Sokol PA. 2008. A LysR-type transcriptional regulator in Burkholderia cenocepacia influences colony morphology and virulence. Infect. Immun. 76:38-47. http://dx.doi.org/10.1128/IAI.00874-07.